**Core Concept**
Platelet aggregation is a crucial process in hemostasis, where platelets clump together to form a platelet plug at the site of vascular injury. This process is mediated by various chemical signals and cellular interactions.

**Why the Correct Answer is Right**
The correct answer involves the activation of platelets by **thromboxane A2 (TXA2)**, a potent vasoconstrictor and platelet aggregator produced by the enzyme **cyclooxygenase (COX)** in platelet-rich plasma. TXA2 binds to its receptor on platelets, leading to an increase in intracellular calcium, activation of protein kinase C, and subsequent platelet aggregation. This process is also facilitated by the release of **adenosine diphosphate (ADP)** and **calcium ions (Ca2+)** from activated platelets.

**Why Each Wrong Option is Incorrect**
**Option A:** This option does not accurately describe the primary cause of platelet aggregation. While **histamine** can cause vasoconstriction and vasodilation, it is not directly involved in platelet aggregation.
**Option B:** **Serotonin (5-HT)** is involved in platelet aggregation, but it is not the primary mediator. Serotonin acts on its receptor to increase platelet adhesiveness and promote aggregation.
**Option C:** **Fibrinogen** is a key protein involved in platelet aggregation, but it is not the primary cause. Fibrinogen binds to the glycoprotein IIb/IIIa receptor on activated platelets, facilitating platelet aggregation and clot formation.

**Clinical Pearl / High-Yield Fact**
TXA2 is a key player in platelet aggregation, and its synthesis is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, which irreversibly inhibit COX-1 and reduce platelet aggregation.

**Correct Answer:** D. Thromboxane A2 (TXA2)